tirzepatide lilly direct Lilly's Mounjaro receives FDA approval for type 2 diabetes treatment Eli Lilly to sell Zepbound

We ask whether a cognitive-computational index of motivationreliably linked to neuropsychiatric symptomsis altered in the context of type-2 diabetes and treatment with a GLP-1 agonist (semaglutide)

doi:10.1056/NEJMoa2206038 [5]4

36 : 641649A

And, much like a cholesterol or arthritis drug, they do not rely on willpower to achieve desired results

Among its strengths is its status as the largest study to date that focuses on the association between GLP-1 RA usage and the risk of psychiatric outcomes in real-world scenarios

A meta-analysis reported a weight loss of 4.19 kg (4.16%), a decrease in body mass index of 1.55 kg/m 2 , and a decrease in waist circumference of 3.11 cm when liraglutide was used [12]